Categories: News

Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI

New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions

- Advertisement -

LONDON, Nov. 24, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of Derwent Patent Monitor to streamline intellectual property (IP) and research and development (R&D) collaborative patent reviews when determining patentability, assessing freedom to operate (FTO) and evaluating opposition or assertion. Built with proprietary data, Derwent Patent Monitor offers AI-powered evaluation of potential threats helping to accelerate first-pass reviews (Threat Analysis) to surface the most critical risks for stakeholders. This feature empowers patent professionals to proceed quickly and with higher confidence.

- Advertisement -

Shandon Quinn, Vice President, Patent Intelligence, Clarivate, said: “One of the biggest challenges IP leaders mention to me is upgrading their team’s partnership with R&D for filing stronger patents and minimizing infringement risk.  Yet too often the process is slowed down by siloed teams and disjointed tools and processes. Derwent Patent Monitor is the first tool of its kind to bring together flexible collaboration and review workflows, unique Derwent patent data and AI technology to help teams quickly identify potential risks and accelerate critical IP decisions for FTO, opposition and patent filing.”

- Advertisement -

The new software is built on proprietary data from the Derwent World Patents Index (DWPI), the world’s most comprehensive database of 67m+ invention summaries written by 850+ Clarivate subject matter experts to help collaborators save time when reviewing patents of interest.

- Advertisement -

Purpose-built for collaboration, Derwent Patent Monitor helps patent teams save time and boost efficiency through structured, project-based reviews and real-time feedback – eliminating the need for scattered emails and spreadsheets. Teams become more aligned and informed on key reviews, enabling a faster, more connected patent monitoring process.

- Advertisement -

To learn more, please visit Derwent Patent Monitor.

- Advertisement -

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

- Advertisement -

Media contact:
Sofia Nogués, Sr. External Communications Manager
newsroom@clarivate.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-launches-derwent-patent-monitor-to-enable-fast-and-accurate-decision-making-with-ai-302623282.html

- Advertisement -

Recent Posts

Charles Winslow Completes Annual Internal Strategic Review at Lumena Intelligent Alliance Office

Jersey City, NJ, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Lumena Intelligent Alliance Office confirmed that…

8 hours ago

DebitMyData Human Energy Grid: The Trillion-Dollar Infrastructure Play That Genesis Executive Order Validates

DebitMyData™ Logo FORT LAUDERDALE, Fla., Dec. 25, 2025 (GLOBE NEWSWIRE) -- DebitMyData, Inc., having oversubscribed…

8 hours ago

Yoolax Announces a Milestone 2025 of Growth, Smart Innovation, and Customer Trust

HongKong, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Yoolax, a leading brand in the motorized window…

8 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

11 hours ago

ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain

December 24, 2025 13:05 ET  | Source: ImmuCell Corporation PORTLAND, Maine, Dec. 24, 2025 (GLOBE…

11 hours ago

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK)…

11 hours ago